Cardiotoxicity of non-cardiovascular drugs (Record no. 109502)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 03313nam a2200349 a 4500 |
001 - CONTROL NUMBER | |
control field | 0000120353 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20171002060421.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m u |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr cn||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 091230s2010 enkaf sb 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER | |
Canceled/invalid LC control number | 2009052142 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Canceled/invalid ISBN | 9780470772744 (cloth) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Canceled/invalid ISBN | 9780470660386 (e-book) |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (CaPaEBR)ebr10380981 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)612432607 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | CaPaEBR |
Transcribing agency | CaPaEBR |
050 14 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RC677 |
Item number | .C365 2010eb |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 616.1/061 |
Edition number | 22 |
245 00 - TITLE STATEMENT | |
Title | Cardiotoxicity of non-cardiovascular drugs |
Medium | [electronic resource] / |
Statement of responsibility, etc. | editor, Giorgio Minotti. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | Chichester, West Sussex : |
Name of publisher, distributor, etc. | Wiley, |
Date of publication, distribution, etc. | 2010. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | xvi, 342 p., [2] p. of plates : |
Other physical details | ill. (some col.) |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc. note | Includes bibliographical references and index. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Machine generated contents note: List of Contributors -- 1. Mitochondrial Dysfunction In Cell Injury and Cardiotoxicity -- Fabio Di Lisa, Martina Semenzato, Andrea Carpi, Sara Menazza, Nina Kaludercic, Roberta Menabò, Marcella Canton -- 2. Cardiovascular Liabilities of Drugs: Regulatory Aspects -- Claudio Arrigoni -- 3. Cellular Mechanisms, Molecular Targets, and Structure-Function Relationships In Drug-Induced Arrhythmias: The Case Of Antihistamines, Psychoactive Drugs, and Antimicrobial Agents -- Maria Virginia Soldovieri and Maurizio Taglialatela -- 4. Cardiovascular Toxicity of Antitumor Drugs: Dimensions of the Problem in Children -- Rebecca Scully, Louis Pruitt, Steven E. Lipshultz -- 5. Cardiovascular Toxicity of Antitumor Drugs: Dimension of the Problem in Adult Settings -- Joseph R. Carver and Chaitali J. Desai -- 6. Diagnostic Aspects of Cardiovascular Toxicity of Antitumor Drugs -- Michael S. Ewer, Thomas M. Suter -- 7. Cardiovascular Toxicity of Antitumor Drugs: Translating Molecular Mechanisms into Clinical Facts -- Pierantonio Menna, Emanuela Salvatorelli, Carlo Salsano, Luca Gianni*, and Giorgio Minotti -- 8. NSAID Action and the Foundations for Cardiovascular Toxicity -- Anna L. Blobaum and Lawrence J. Marnett -- 9. Cardiovascular toxicities of NSAIDS: Epidemiologic aspects -- Antonio González-Pe;rez, Luis Alberto Garci;a Rodriguez -- 10. Cardiovascular Toxicities of Life-Saving Drugs: Antiviral Therapy -- James J. Kohler & William Lewis. |
520 ## - SUMMARY, ETC. | |
Summary, etc. | "First book to deal with this important area of adverse drug reactions -- cardiotoxicity is one of the major forms of toxicity seen in drugs and it accounts for most drug recalls and delays experienced in regulatory approvals. Covers four important therapeutic classes: psychoactive drugs; anticancer drugs; non-steroidal anti-inflammatory drugs; and anti-retroviral drugs. - Emphasis on the preclinical screening of drug cardiotoxicity, to enable drug developers to test for this toxicity before starting expensive clinical trials"--Provided by publisher. |
533 ## - REPRODUCTION NOTE | |
Type of reproduction | Electronic reproduction. |
Place of reproduction | Palo Alto, Calif. : |
Agency responsible for reproduction | ebrary, |
Date of reproduction | 2010. |
Note about reproduction | Available via World Wide Web. |
-- | Access may be limited to ebrary affiliated libraries. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cardiovascular toxicology. |
655 #7 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
Source of term | local |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Minotti, Giorgio. |
710 2# - ADDED ENTRY--CORPORATE NAME | |
Corporate name or jurisdiction name as entry element | ebrary, Inc. |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="http://site.ebrary.com/lib/daystar/Doc?id=10380981">http://site.ebrary.com/lib/daystar/Doc?id=10380981</a> |
Public note | An electronic book accessible through the World Wide Web; click to view |
908 ## - PUT COMMAND PARAMETER (RLIN) | |
Put command parameter | 170314 |
942 00 - ADDED ENTRY ELEMENTS (KOHA) | |
Koha item type | Electronic Book |
No items available.